These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33400411)

  • 1. Intradermal Microdroplet Injection of Diluted Incobotulinumtoxin-A for Sebum Control, Face Lifting, and Pore Size Improvement.
    Park JY; Cho SI; Hur K; Lee DH
    J Drugs Dermatol; 2021 Jan; 20(1):49-54. PubMed ID: 33400411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intradermal botulinum toxin to reduce sebum production and facial pore size.
    Shah AR
    J Drugs Dermatol; 2008 Sep; 7(9):847-50. PubMed ID: 19112798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of intradermal injections of botulinum toxin in the management of enlarged facial pores and seborrhea: a split face-controlled study.
    Sayed KS; Hegazy R; Gawdat HI; Abdel Hay RM; Ahmed MM; Mohammed FN; Allam R; Fahim A
    J Dermatolog Treat; 2021 Nov; 32(7):771-777. PubMed ID: 31865815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin.
    Rose AE; Goldberg DJ
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):443-8. PubMed ID: 23293895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema.
    Kim MJ; Kim JH; Cheon HI; Hur MS; Han SH; Lee YW; Choe YB; Ahn KJ
    Dermatol Surg; 2019 Sep; 45(9):1155-1162. PubMed ID: 30730346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Neurotoxin Type A in the Treatment of Facial Seborrhea and Acne: Evidence and a Proposed Mechanism.
    Rho NK; Gil YC
    Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split face comparison between common concentration vs double dilution of intradermal abobotulinum toxin type A (Dysport) injection for facial lifting in Asians.
    Sirithanabadeekul P; Lapsomboonsiri S; Rungjang A; Thanasarnaksorn W
    J Cosmet Dermatol; 2018 Jun; 17(3):355-360. PubMed ID: 29878718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and possible mechanisms of botulinum toxin treatment of oily skin.
    Shuo L; Ting Y; KeLun W; Rui Z; Rui Z; Hang W
    J Cosmet Dermatol; 2019 Apr; 18(2):451-457. PubMed ID: 30697928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Treatment with Micro-Focused Ultrasound with Visualization and Intradermal Incobotulinumtoxin-A for Enlarged Facial Pores: A Retrospective Study in Asians.
    Park JY; Lee JS; Lee SR; Lee DH
    Clin Cosmet Investig Dermatol; 2023; 16():1249-1255. PubMed ID: 37215534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparison between intradermal injection of abobotulinumtoxinA and normal saline for face-lifting: a split-face randomized controlled trial.
    Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Rojanavanich V; Phothong W; Manuskiatti W
    J Cosmet Dermatol; 2016 Dec; 15(4):452-457. PubMed ID: 27647769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Double-Blind, Split-Face, Randomized Study on the Effects and Safety of Intradermal Injection of Botulinum Toxin A (Incobotulinum Toxin A) in the Cheek.
    Shin DM; Lee J; Noh H; Jang D; Oh SJ; Park JH; Lee JH
    Ann Dermatol; 2022 Dec; 34(6):442-450. PubMed ID: 36478426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtoxin for Improving Pore Size, Skin Laxity, Sebum Control, and Scars: A Roundtable on Integrating Intradermal Botulinum Toxin Type A Microdoses Into Clinical Practice.
    Fabi SG; Park JY; Goldie K; Wu W
    Aesthet Surg J; 2023 Aug; 43(9):1015-1024. PubMed ID: 36857534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of IGF-1 are related to human skin characteristics including the conspicuousness of facial pores.
    Sugiyama-Nakagiri Y; Naoe A; Ohuchi A; Kitahara T
    Int J Cosmet Sci; 2011 Apr; 33(2):144-9. PubMed ID: 20646082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are There Differences Between Intradermal and Intramuscular Injections of Botulinum Toxin on the Forehead?
    Kim YJ; Lim OK; Choi WJ
    Dermatol Surg; 2020 Dec; 46(12):e126-e131. PubMed ID: 32205751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and instrumental study of the efficacy of a new sebum control cream.
    Dobrev H
    J Cosmet Dermatol; 2007 Jun; 6(2):113-8. PubMed ID: 17524128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Employing microbotox technique for facial rejuvenation and face-lift.
    Iranmanesh B; Khalili M; Mohammadi S; Amiri R; Aflatoonian M
    J Cosmet Dermatol; 2022 Oct; 21(10):4160-4170. PubMed ID: 35064633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal injection of incobotulinumtoxinA for face lifting.
    Wanitphakdeedecha R; Nokdhes YN; Patthamalai P; Yan C; Techapichetvanich T; Phothong W; Eimpunth S; Manuskiatti W
    Dermatol Ther; 2020 Nov; 33(6):e13944. PubMed ID: 32614987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midface lifting with botulinum toxin: intradermal technique.
    Petchngaovilai C
    J Cosmet Dermatol; 2009 Dec; 8(4):312-6. PubMed ID: 19958437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study.
    Fischer T; Sattler G; Prager W; Rzany B; Pavicic T; Gauglitz G; Weissenberger P; Riaz S
    J Drugs Dermatol; 2020 May; 19(5):461-469. PubMed ID: 32484631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal Botulinum Toxin A Injection for Scalp Sebum Secretion Regulation: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Prospective Study in Chinese Subjects.
    Li Y; Chen X; Luo X; Li L; Lin Y
    Aesthet Surg J; 2023 Jan; 43(1):NP38-NP48. PubMed ID: 36004504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.